TNFRSF17 and plasma cell myeloma: The assumption of synergy between treatment modalities is also supported by a case of a patient with relapsed/refractory multiple myeloma given B-cell maturation antigen (BCMA)-targeted CAR T-cell therapy followed by radiation therapy for spinal cord compression.